Cargando…
Galectin-9/TIM-3 as a Key Regulator of Immune Response in Gliomas With Chromosome 1p/19q Codeletion
Gliomas with chromosome 1p/19q codeletion were considered a specific tumor entity. This study was designed to reveal the biological function alterations tightly associated with 1p/19q codeletion in gliomas. Clinicopathological and RNA sequencing data from glioma patients were obtained from The Cance...
Autores principales: | Li, Guanzhang, Huang, Ruoyu, Fan, Wenhua, Wang, Di, Wu, Fan, Zeng, Fan, Yu, Mingchen, Zhai, You, Chang, Yuanhao, Pan, Changqing, Jiang, Tao, Yan, Wei, Wang, Hongjun, Zhang, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8692744/ https://www.ncbi.nlm.nih.gov/pubmed/34956239 http://dx.doi.org/10.3389/fimmu.2021.800928 |
Ejemplares similares
-
Clinical characterization and immunosuppressive regulation of CD161 (KLRB1) in glioma through 916 samples
por: Di, Wang, et al.
Publicado: (2021) -
TREM2 is associated with tumor immunity and implies poor prognosis in glioma
por: Yu, Mingchen, et al.
Publicado: (2023) -
Effects of 1p/19q Codeletion on Immune Phenotype in Low Grade Glioma
por: Lv, Lei, et al.
Publicado: (2021) -
RNA editing-based classification of diffuse gliomas: predicting isocitrate dehydrogenase mutation and chromosome 1p/19q codeletion
por: Chen, Sean Chun-Chang, et al.
Publicado: (2019) -
How I treat anaplastic glioma without 1p/19q codeletion
por: Berghoff, Anna, et al.
Publicado: (2019)